SILVER SPRING, Md. (AP) _ United Therapeutics Corp. (UTHR) on Wednesday reported second-quarter profit of $116 million.
The Silver Spring, Maryland-based company said it had profit of $2.41 per share.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $4.10 per share.
The drugmaker posted revenue of $466.9 million in the period, topping Street forecasts. Five analysts surveyed by Zacks expected...
READ MORE
SILVER SPRING, Md. (AP) _ United Therapeutics Corp. (UTHR) on Wednesday reported second-quarter profit of $116 million.
The Silver Spring, Maryland-based company said it had profit of $2.41 per share.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $4.10 per share.
The drugmaker posted revenue of $466.9 million in the period, topping Street forecasts. Five analysts surveyed by Zacks expected $463 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on UTHR at https://www.zacks.com/ap/UTHR
Copyright
© 2022 . All rights reserved. This website is not intended for users located within the European Economic Area.